Drug class · Endocrine & metabolism
Insulins and insulin analogs Drug Codes & NDCs
Human insulin and modified insulin molecules (analogs), supplied in vials, cartridges and prefilled pens.
FDA-listed products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Novolin Rhuman insulin | Insulin human 100 [iU]/mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-3003 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2100 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-2101 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-3303 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6338 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-6339 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | Novo Nordisk | 0169-7501 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1664 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-1678 |
| Novologinsulin aspart | Insulin aspart 100 [iU]/mL | Injection, SolutionIntravenous, Subcutaneous | A-S Medication Solutions | 50090-4500 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2200 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-2201 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3685 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | Novo Nordisk Pharmaceutical Industries, LP | 0169-3696 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | A-S Medication Solutions | 50090-2272 |
| NovoLog Mix 70/30insulin aspart | Insulin aspart 100 [iU]/mL | Injection, SuspensionSubcutaneous | REMEDYREPACK INC. | 70518-2119 |
| Pancreas DB Liquescence 3037pancreas db liquescence | Trillium erectum root 1 [hp_X]/118mL + 17 more ingredients | LiquidOral | Professional Complementary Health Formulas | 63083-3037 |
| Pancreas Liquescencecinnamomum, gymnema sylvestre, phosphoricum acidum, syzygium jambolanum, trigonella foenum-graceum, argentum nitricum, chionanthus virginica, hepar suis, pancreas suis, rhus aromatica, sulphur, lycopodium clavatum, chromium picolinate, chromium metallicum, phosphorus, vanadium metallicum, zincum metallicum, murex purpurea, dna, insulinum (human), uranium nitricum | Cinnamon 3 [hp_X]/mL + 20 more ingredients | LiquidOral | Nutritional Specialties, Inc. | 83027-0026 |
| Professional Weight Supportasclepias vincetoxicum, echinacea (angustifolia), hypothalamus (suis), hepar suis, kidney (suis), methylcobalamin, gambogia, graphites, nux vomica, phytolacca decandra, 7-oxo-dehydroepiandrosterone 3b-acetate, adenosinum triphosphoricum dinatrum, insulinum (human), pancreas suis, sarcolacticum acidum, proteus (vulgaris) | Vincetoxicum hirundinaria root 6 [hp_X]/1 + 15 more ingredients | TabletOral | Deseret Biologicals | 43742-2048 |
| Rezvoglar KwikPeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8980 |
| Rezvoglar Kwikpeninsulin glargine-aglr | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | A-S Medication Solutions | 50090-6439 |
| Semgleeinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-011 |
| Semgleeinsulin glargine-yfgn | Insulin glargine 100 [iU]/mL | Injection, SolutionSubcutaneous | Biocon Biologics Inc. | 83257-012 |
| Set 4Te Homoadeps suillus, bryonia (alba), calcarea phosphorica, cholinum, dna, dopamine (hydrochloride), ferrum phosphoricum, folic acid, insulinum (human), leptin, magnesia muriatica, l-methionine, methylcobalamin, proteus (vulgaris), rhus tox, riboflavinum, ruta graveolens, saccharum officinale, thiosinaminum, zincum metallicum | Lard 9 [hp_X]/mL + 19 more ingredients | LiquidOral | Deseret Biologicals, Inc. | 43742-2552 |
| Soliqua 100/33insulin glargine and lixisenatide | Insulin glargine 100 U/mL; Lixisenatide 33 ug/mL | Injection, SolutionSubcutaneous | Sanofi-Aventis U.S. LLC | 0024-5761 |